HEALTHCARE INSIGHTS
HEALTHCARE INSIGHTS
  • Home
  • #Global Trends
  • #Local Dynamics
  • #M&A
  • #Regulations
  • #Knowledge
    • #Corporate Wellness
    • #Human Resources
    • #Capability Development
    HEALTHCARE INSIGHTS
    HEALTHCARE INSIGHTS

    Category: Uncategorized

    Emergency Coagulant Withdrawn from U.S. Market Following Safety Concerns

    23/12/2025 Published by vivi

    As of December 22, 2025, AstraZeneca has officially ceased all production and commercial sales of Andexxa in the United States.... Read more

    Category: Uncategorized
    Tags: #Global Trends

    UK Authorizes Twice-Yearly Injectable for HIV Prevention

    23/12/2025 Published by vivi

    The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has officially granted marketing authorization for lenacapavir (branded as Yeytuo) for... Read more

    Category: Uncategorized
    Tags: #Global Trends

    A New Chapter in Obesity Management: The Emergence of Oral Weight-Loss Medications

    23/12/2025 Published by vivi

    The healthcare industry has reached a significant milestone with the FDA's official approval of the tablet version of semaglutide (Wegovy).... Read more

    Category: Uncategorized
    Tags: #Global Trends

    White House Secures Pricing Accords with Nine Additional Pharmaceutical Giants

    23/12/2025 Published by vivi

    In a major step toward implementing the "Most-Favored-Nation" (MFN) pricing policy, the Trump administration has announced individual agreements with nine... Read more

    Category: Uncategorized
    Tags: #Global Trends

    AstraZeneca Inks $2 Billion Deal to Secure Next-Generation Cancer Inhibition Technology

    23/12/2025 Published by vivi

    AstraZeneca has officially entered into a global licensing agreement worth up to $2 billion for Jacobio Pharma’s Pan-KRAS inhibitor candidate,... Read more

    Category: Uncategorized
    Tags: #M&A

    Korean Bio-Pharma Giant Establishes First Manufacturing Foothold in the United States

    23/12/2025 Published by vivi

    Samsung Biologics has secured a $280 million deal to acquire GSK’s manufacturing facilities located in Rockville, Maryland. This strategic move... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Rare Disease Market Shifts as Shionogi Inks $2.5 Billion Asset Acquisition

    23/12/2025 Published by vivi

    On December 22, Shionogi revealed a definitive agreement to acquire the amyotrophic lateral sclerosis (ALS) portfolio from Tanabe Pharma. The... Read more

    Category: Uncategorized
    Tags: #M&A

    Obesity Treatment Frontier: FDA Approves First-Ever Oral GLP-1 Tablet

    23/12/2025 Published by vivi

    The global healthcare market has reached a historic milestone with the FDA's official approval of the oral tablet formulation of... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Unauthorized Clinic in Hue Shutdown Following Severe Regulatory Violations

    23/12/2025 Published by vivi

    On December 22, the Hue City Department of Health announced an administrative penalty against the Mb Center (located on To... Read more

    Category: Uncategorized
    Tags: #Local Dynamics

    Posts pagination

    Previous page Page 1 … Page 43 Page 44 Page 45 … Page 64 Next page

    Facebook

    Map

    Workday: Monday to Friday
    Working hours: 8am to 5pm
    Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

    Please enable JavaScript in your browser to complete this form.
    Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates
    Loading

    Online Members

    Recent Comments

    • GauTruc on New Biotech Startup Secures $125 Million to Advance Pain Medication
    HEALTHCARE INSIGHTS
    All rights reserved